| Click for the Finfacts Ireland Portal Homepage |

Finfacts Business News Centre

 Irish Economy
 EU Economy
 US Economy
 UK Economy
 Global Economy
 Asia Economy


How to use our RSS feed

Follow Finfacts on Twitter

Web Finfacts

See Search Box lower down this column for searches of Finfacts news pages. Where there may be the odd special character missing from an older page, it's a problem that developed when Interactive Tools upgraded to a new content management system.


Finfacts is Ireland's leading business information site and you are in its business news section.


Finfacts Homepage

Irish Share Prices

Euribor Daily Rates

Irish Economy

Global Income Per Capita

Global Cost of Living

Irish Tax - Income/Corporate

Global News

Bloomberg News

CNN Money

Cnet Tech News


Irish Independent

Irish Times

Irish Examiner

New York Times

Financial Times

Technology News




Content Management by interactivetools.com.

News : US Economy Last Updated: Nov 19, 2014 - 8:22 AM

Tax-inverted "Irish" firm Actavis agrees to buy US Botox maker Allergan
By Michael Hennigan, Finfacts founder and editor
Nov 18, 2014 - 8:14 AM

Email this article
 Printer friendly page

Actavis plc, which is technically an "Irish company" following the transfer for tax purposes of its headquarters to Dublin in 2013, but remains a US firm in real-world-terms, on Monday announced a $66bn deal for Allergan Inc, the maker of Botox, the skin cavity filler.

Actavis was known for its generic drugs, but last year it bought the smaller Warner Chilcott, an Irish provider of branded treatments for gastrointestinal and urological conditions, and this is how it became Irish:

Finfacts: US-Ireland Tax Inversions 600,000+ staff: Kenny, Noonan met with top US corporate lawyers

Actavis plc is listed on the New Stock Exchange, and it says while its global headquarters is located in Dublin, Ireland, its administrative headquarters is based in Parsippany, New Jersey, USA.

Allergan has about 900 employed at its Irish facilities in Westport, County Mayo.

The combined company would sell a range of eye, skin and stomach drugs, led by the well known brand Botox. The company would have $23bn in sales in 2015, more than 30,000 employees and a market capitalization of $128bn, about 12 times Actavis’s equity value just two years ago.

This takeover is going to add to the distortions in Ireland's national accounts.

Finfacts: The idiot/ eejit's guide to distorted Irish national economic data

The Wall Street Journal says Actavis’s entry into the ranks of Big Pharma will come at a hefty price for the company, its many employees and US tax coffers. To reach its financial targets, Actavis plans to cut at least $1.8bn in costs, including $400m in research spending. That doesn’t include $475m in costs Allergan already planned to cut since it came under pressure from hostile suitor Valeant Pharmaceuticals International Inc.

"The Dublin-based company is expected to have a 15% corporate tax rate. That could save the combined company hundreds of millions of dollars in taxes that California-based Allergan would have paid at a roughly 26% tax rate.

To put Valeant out of reach, Actavis’s offer pays $85.08 a share more than the value of Allergan stock before the company was put in play in April."

© Copyright 2011 by Finfacts.com

Top of Page

US Economy
Latest Headlines
US jobs rose by 215,000 in July; Unemployment rate stable at 5.3%
US economy grew at weak pace in Q2 2015 - Worst expansion since 1945
Decoupling of per capita GDP, productivity, private employment, and median family income in America
US economy stumbles again in 2015
Income gap highest in 30 years; No inequality rise in best-paying US firms
Fed minutes raise doubts about fragility of US recovery
Senate Democrats block trade deal authority for Obama
Five firms held 25% of top US non-financial companies cash pile in 2014
US added 223,000 jobs in April; Broad jobless rate at 10.8%
Investment struggles as dividends/ share buybacks at top US firms to exceed $1tn in 2015
US economic growth plunged in Q1 2015
Why the Fed may (almost) never raise interest rates
US jobless rate falls to 5.5%; Broad rate at 11%; Participation rate at 1978 level
US added 257,000 jobs in January; Broad jobless rate at 11.3%
US economy will soon see best years in a decade
US annualised GDP slowed sharply in final quarter 2014
US budget deficit to fall to 2.6% of GDP in 2015
US added 252,000 jobs in December; Jobless rate falls to 5.6%
US adds 321,000 jobs in November; Private sector adds 10.9m jobs in 57 months of growth
US manufacturing slowed in November
US retail spending over Thanksgiving weekend fell 11%
US consumer spending weak in October; Business investment fell again
US third-quarter GDP revised up to 3.9% annualised rate
After destroying banking secrecy US helps Swiss exporters
US oil imports from OPEC cartel at 30-year low
Tax-inverted "Irish" firm Actavis agrees to buy US Botox maker Allergan
US nonfarm payroll employment rose 214,000 in October' Jobless @ 6-year low
Swiss bankers await fallout of US tax evasion acquittal
Two PMI reports give contrasting trends on US manufacturing
US GDP increased at annualised 3.5% in third quarter of 2014
US city home price growth slowed again in August; Consumer confidence rebounded in September
US new orders for manufactured durable goods fell again in September
Loans to buy US shares at record highs
Global markets slide; US industrial production best in 3 years & jobless claims in 14-year low
US federal budget deficit dips to 2.9% of GDP in fiscal year 2014
US added 248,000 jobs in September; Jobless rate falls to 5.9%
US set to become world’s leading liquid petroleum producer again
Obama issues new rules to combat tax inversions
US Securities and Exchange Commission to pay $30m award to foreign whistleblower
Typical American household income in 2013 was below the 1989 level